Rybak MJ, LeJ LTP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America. Pediatr Am J Health Syst Pharm. 2020;77:835–64.

Article  Google Scholar 

Colin PJ, Allegaert K, Thomson AH, et al. Vancomycin pharmacokinetics throughout life: results from a pooled population analysis and evaluation of current dosing recommendations. Clin Pharmacokinet. 2019;58:767–80.

Article  CAS  PubMed  Google Scholar 

Dao K, Guidi M, André P, et al. Optimisation of vancomycin exposure in neonates based on the best level of evidence. Pharmacol Res. 2020;154:104278.

Article  CAS  PubMed  Google Scholar 

Marsot A, Vialet R, Boulamery A, et al. Vancomycin: predictive performance of a population pharmacokinetic model and optimal dose in neonates and young infants. Clin Pharmacol Drug Dev. 2012;1:144–51.

Article  CAS  PubMed  Google Scholar 

Albanell-Fernández M, Rodríguez-Reyes M, Bastida C, et al. A review of vancomycin, gentamicin, and amikacin population pharmacokinetic models in neonates and infants. Clin Pharmacokinet. 2025;64:1–25.

Article  PubMed  PubMed Central  Google Scholar 

Chen Q, Wan J, Shen W, et al. Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: a retrospective study based on electronic medical records. Pediatr Neonatol. 2022;63:247–54.

Article  PubMed  Google Scholar 

Gao Y, Wu T, Pu L, et al. Identification of vancomycin exposure target in neonates: how much is enough? J Antimicrob Chemother. 2024;79:3344–53.

Article  CAS  PubMed  Google Scholar 

Tang Z, Guan J, Li J, et al. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing. Int J Antimicrob Agents. 2021;57:106300.

Article  CAS  PubMed  Google Scholar 

Smits A, Pauwels S, Oyaert M, et al. Factors impacting unbound vancomycin concentrations in neonates and young infants. Eur J Clin Microbiol Infect Dis. 2018;37:1503–10.

Article  CAS  PubMed  Google Scholar 

Monteiro JF, Hahn SR, Gonçalves J, et al. Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations. Pharmacol Res Perspect. 2018;6:e00420.

Article  PubMed  PubMed Central  Google Scholar 

Downes KJ, Sharova A, Malone J, et al. Multiple model optimal sampling promotes accurate vancomycin area-under-the-curve estimation using a single sample in critically ill children. Ther Drug Monit. 2025. https://doi.org/10.1097/FTD.0000000000001293.

Article  PubMed  PubMed Central  Google Scholar 

Neely MN, Kato L, Youn G, et al. Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing. Antimicrob Agents Chemother. 2018. https://doi.org/10.1128/AAC.02042-17.

Article  PubMed  PubMed Central  Google Scholar 

Finch NA, Zasowski EJ, Murray KP, et al. A quasi-experiment to study the impact of vancomycin area under the concentration-time curve-guided dosing on vancomycin-associated nephrotoxicity. Antimicrob Agents Chemother. 2017. https://doi.org/10.1128/AAC.01293-17.

Article  PubMed  PubMed Central  Google Scholar 

Rybak MJ, Lomaestro BM, Rotscahfer JC, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009;49:325–7.

Article  PubMed  Google Scholar 

Frymoyer A, Guglielmo BJ, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant staphylococcal infections. Pediatr Infect Dis J. 2013;32:1077–9.

Article  PubMed  Google Scholar 

Mould D, D’Haens G, Upton R. Clinical decision support tools: the evolution of a revolution. Clin Pharmacol Ther. 2016;99:405–18.

Article  CAS  PubMed  Google Scholar 

Minichmayr IK, Dreesen E, Centanni M, et al. Model-informed precision dosing: state of the art and future perspectives. Adv Drug Deliv Rev. 2024. https://doi.org/10.1016/j.addr.2024.115421.

Article  PubMed  Google Scholar 

Wicha SG, Märtson AG, Nielsen EI, et al. From therapeutic drug monitoring to model‐informed precision dosing for antibiotics. Clin Pharmacol Ther. 2021;109:928–41.

Article  CAS  PubMed  Google Scholar 

Duong A, Le Blanc J, Projean D, et al. Identifying the optimal sampling strategy for the Bayesian estimation of vancomycin AUC0–24 in adult hematologic cancer patients. Clin Pharmacokinet. 2025;64:297–305.

Article  CAS  PubMed  Google Scholar 

Dubovitskaya A, Buclin T, Schumacher M, et al. Tucuxi, an intelligent system for personalized medicine: from individualization of treatments to research databases and back. In: Proceedings of the 8th ACM international conference on bioinformatics, computational biology, and health informatics; 2017.

Thoma Y, Buclin T. TUCUXI-Core: an open source generic and efficient computing engine for model-informed precision dosing. Smart Health. 2025. https://doi.org/10.1016/j.smhl.2025.100600.

Article  Google Scholar 

Ravix A, Cathignol AE, Buclin T, et al. Numerical verification of Tucuxi, a promising Bayesian adaptation tool for model‐informed precision dosing. CPT Pharmacomet Syst Pharmacol. 2025. https://doi.org/10.1002/psp4.70077.

Article  Google Scholar 

Voigt M, Fusch C, Olbertz D, et al. Analyse des Neugeborenenkollektivs der Bundesrepublik Deutschland. Geburtshilfe Frauenheilkd. 2006;66:956–70.

Article  Google Scholar 

Swiss society of paediatrics. Paediatric Growth Curves. [web site] 2011.

SwissMedicInfo. Vancomycin Sandoz® i.v. [web site] 11/2023. https://www.swissmedicinfo.ch/ViewMonographie. Accessed 13 Feb 2025.

Ainsworth S. Neonatal Formulary: drug use in pregnancy and the first year of life. Vancomycin. (seven edition); 2015;520–2.

SwissPedDose. Vancomycin (IV). General use (neonatology). [web site] 01/14/2025. https://db.swisspeddose.ch/search/?_search_en=vanco. Accessed 13 Feb 2025.

El Hassani M, Blouin M, Marsot A. A simulation study to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonates. Br J Clin Pharmacol. 2024. https://doi.org/10.1111/bcp.16345.

Article  PubMed  Google Scholar 

Uster DW, Wicha SG. Optimized sampling to estimate vancomycin drug exposure: comparison of pharmacometric and equation‐based approaches in a simulation‐estimation study. CPT Pharmacomet Syst Pharmacol. 2022;11:711–20.

Article  CAS  Google Scholar 

Shingde RV, Reuter SE, Graham GG, et al. Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure. J Antimicrob Chemother. 2020;75:3293–302.

Article  CAS  PubMed  Google Scholar 

Oda K, Yamada T, Matsumoto K, et al. Model‐informed precision dosing of vancomycin for rapid achievement of target area under the concentration‐time curve: a simulation study. Clin Transl Sci. 2023;16:2265–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hughes JH, Tong DMH, Faldasz JD, et al. Evaluation of neonatal and paediatric vancomycin pharmacokinetic models and the impact of maturation and serum creatinine covariates in a large multicentre data set. Clin Pharmacokinet. 2023;62:67–76.

Article  CAS  PubMed  Google Scholar 

Frymoyer A, Schwenk HT, Zorn Y, et al. Model-informed precision dosing of vancomycin in hospitalized children: implementation and adoption at an academic children’s hospital. Front Pharmacol. 2020. https://doi.org/10.3389/fphar.2020.00551.

Article  PubMed  PubMed Central  Google Scholar 

Seng JJB, Yong MHA, Peh ZX, et al. Appropriateness of vancomycin therapeutic drug monitoring and its outcomes among non-dialysis patients in a tertiary hospital in Singapore. Int J Clin Pharm. 2018;40:977–81.

Article  CAS  PubMed  Google Scholar 

Del Valle-Moreno P, Suarez-Casillas P, Mejías-Trueba M, et al. Model-informed precision dosing software tools for dosage regimen individualization: a scoping review. Pharmaceutics. 2023;15:1859.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frymoyer A, Stockmann C, Hersh AL, et al. Individualized empiric vancomycin dosing in neonates using a model-based approach. J Pediatr Infect Dis Soc. 2019;8:97–104.

Article